Viking Therapeutics (VKTX) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to -$1.39.
- Viking Therapeutics' EPS (Basic) fell 33437.5% to -$1.39 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.19, marking a year-over-year decrease of 21900.0%. This contributed to the annual value of -$3.19 for FY2025, which is 21584.16% down from last year.
- Viking Therapeutics' EPS (Basic) amounted to -$1.39 in Q4 2025, which was down 33437.5% from -$0.81 recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' EPS (Basic) registered a high of -$0.16 during Q4 2021, and its lowest value of -$1.39 during Q4 2025.
- Moreover, its 5-year median value for EPS (Basic) was -$0.23 (2022), whereas its average is -$0.34.
- As far as peak fluctuations go, Viking Therapeutics' EPS (Basic) surged by 1739.13% in 2023, and later plummeted by 33437.5% in 2025.
- Quarter analysis of 5 years shows Viking Therapeutics' EPS (Basic) stood at -$0.16 in 2021, then plummeted by 62.5% to -$0.26 in 2022, then increased by 3.85% to -$0.25 in 2023, then fell by 28.0% to -$0.32 in 2024, then plummeted by 334.37% to -$1.39 in 2025.
- Its EPS (Basic) was -$1.39 in Q4 2025, compared to -$0.81 in Q3 2025 and -$0.58 in Q2 2025.